BCYC
Price
$6.93
Change
-$0.31 (-4.28%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
501.4M
31 days until earnings call
RPTX
Price
$1.40
Change
+$0.01 (+0.72%)
Updated
Jun 30, 03:00 PM (EDT)
Capitalization
59.62M
37 days until earnings call
Interact to see
Advertisement

BCYC vs RPTX

Header iconBCYC vs RPTX Comparison
Open Charts BCYC vs RPTXBanner chart's image
Bicycle Therapeutics
Price$6.93
Change-$0.31 (-4.28%)
Volume$8.49K
Capitalization501.4M
Repare Therapeutics
Price$1.40
Change+$0.01 (+0.72%)
Volume$100
Capitalization59.62M
BCYC vs RPTX Comparison Chart in %
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. RPTX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and RPTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (BCYC: $7.24 vs. RPTX: $1.39)
Brand notoriety: BCYC and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 69% vs. RPTX: 57%
Market capitalization -- BCYC: $501.4M vs. RPTX: $59.62M
BCYC [@Biotechnology] is valued at $501.4M. RPTX’s [@Biotechnology] market capitalization is $59.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while RPTX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 5 bearish.
  • RPTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BCYC and RPTX are a good buy in the short-term.

Price Growth

BCYC (@Biotechnology) experienced а -2.43% price change this week, while RPTX (@Biotechnology) price change was -1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

BCYC is expected to report earnings on Jul 31, 2025.

RPTX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($501M) has a higher market cap than RPTX($59.6M). RPTX YTD gains are higher at: 6.107 vs. BCYC (-48.286). RPTX has higher annual earnings (EBITDA): -128.28M vs. BCYC (-200.61M). BCYC has more cash in the bank: 793M vs. RPTX (124M). RPTX has less debt than BCYC: RPTX (1.37M) vs BCYC (8.33M). BCYC has higher revenues than RPTX: BCYC (25.7M) vs RPTX (1.07M).
BCYCRPTXBCYC / RPTX
Capitalization501M59.6M841%
EBITDA-200.61M-128.28M156%
Gain YTD-48.2866.107-791%
P/E RatioN/AN/A-
Revenue25.7M1.07M2,395%
Total Cash793M124M640%
Total Debt8.33M1.37M607%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCRPTX
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
86%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVGX16.240.16
+1.00%
Lord Abbett International Growth R6
PGTDX62.660.16
+0.26%
Putnam Global Technology C
MDFSX7.690.02
+0.26%
Manning & Napier Disciplined Value S
FSDIX17.500.04
+0.23%
Fidelity Strategic Dividend & Income
TVIFX82.070.12
+0.15%
Thornburg Small/Mid Cap Core I

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with INO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.55%
INO - BCYC
55%
Loosely correlated
-6.22%
XNCR - BCYC
55%
Loosely correlated
-3.10%
RLAY - BCYC
51%
Loosely correlated
-0.60%
RPTX - BCYC
48%
Loosely correlated
-1.42%
RARE - BCYC
45%
Loosely correlated
-2.43%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-1.42%
INO - RPTX
58%
Loosely correlated
-6.22%
BCYC - RPTX
48%
Loosely correlated
-0.55%
CADL - RPTX
43%
Loosely correlated
N/A
EDIT - RPTX
34%
Loosely correlated
+7.55%
PALI - RPTX
31%
Poorly correlated
-1.93%
More